Executive Insight Reports
Insights
Long-form executive analysis from Hill Research's Clinical AI Mastermind series and other curated forums. Senior pharma, biotech, and regulatory leaders on what it takes to deploy AI in real-world clinical environments — published a few weeks after each event.
Four reports planned for 2026, tracking the year's arc on scale, agility, integrity, and what comes next in clinical AI.
Industrializing Clinical Biometrics: What the Room Found
Executive Insight Report - Clinical AI Mastermind 2026, Session 2
Deep-dive executive analysis of the July 29, 2026 Clinical AI Mastermind at Johnson & Johnson in Cambridge. Senior biometrics, data science and clinical development leaders on what it takes to move clinical biometrics from individual AI pilots to enterprise scale.
Read the full report →
The Submission Last-Mile: What the Room Found
Executive Insight Report — Clinical AI Mastermind 2026, Session 1
Deep-dive executive analysis of the May 20, 2026 Clinical AI Mastermind at Johnson & Johnson Innovative Medicine. 48 senior leaders from pharma, biotech, regulatory, and clinical AI on what it takes to scale AI through the FDA submission Last-Mile.
Read the full report →Want to Join the Conversation?
The Clinical AI Mastermind series is invitation-based. If you lead clinical AI, biometrics, or regulatory data science at a sponsor, CRO, or regulator, we'd like to hear from you.